S&P 500 Futures
(0.14%) 5 161.75 points
Dow Jones Futures
(0.12%) 38 878 points
Nasdaq Futures
(0.08%) 18 016 points
Oil
(0.86%) $78.78
Gas
(0.42%) $2.15
Gold
(0.97%) $2 331.00
Silver
(2.58%) $27.38
Platinum
(0.45%) $969.65
USD/EUR
(0.05%) $0.929
USD/NOK
(-0.20%) $10.85
USD/GBP
(-0.18%) $0.796
USD/RUB
(0.10%) $91.54

Echtzeitaktualisierungen für Spectral Medical Inc [EDT.TO]

Börse: TSX Industrie: Diagnostics & Research
Upcoming Earnings Alert

3 days till quarter result
(bmo 2024-05-09)

Expected move: +/- 3.95%

Zuletzt aktualisiert3 Mai 2024 @ 21:59

-3.37% $ 0.430

Live Chart Being Loaded With Signals

Commentary (3 Mai 2024 @ 21:59):

Spectral Medical Inc., together with its subsidiaries, focuses on the development and commercialization of products for the treatment of septic shock and renal disease in North America...

Stats
Tagesvolumen 5 317.00
Durchschnittsvolumen 75 466.00
Marktkapitalisierung 119.79M
EPS $0 ( 2024-03-25 )
Nächstes Ertragsdatum ( $0 ) 2024-05-09
Last Dividend $0.120 ( 2011-12-19 )
Next Dividend $0 ( N/A )
P/E -7.17
ATR14 $0 (0.00%)

Spectral Medical Inc Korrelation

10 Am meisten positiv korreliert
10 Am meisten negativ korreliert

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Spectral Medical Inc Finanzdaten

Annual 2023
Umsatz: $1.60M
Bruttogewinn: $-4.81M (-301.06 %)
EPS: $-0.0562
FY 2023
Umsatz: $1.60M
Bruttogewinn: $-4.81M (-301.06 %)
EPS: $-0.0562
FY 2022
Umsatz: $1.67M
Bruttogewinn: $983 000 (58.97 %)
EPS: $-0.0419
FY 2021
Umsatz: $2.05M
Bruttogewinn: $1.22M (59.45 %)
EPS: $-0.0300

Financial Reports:

No articles found.

Spectral Medical Inc Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

Spectral Medical Inc Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future
Information
First Dividend $0.120 2011-12-19
Last Dividend $0.120 2011-12-19
Next Dividend $0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 1 --
Total Paid Out $0.120 --
Avg. Dividend % Per Year 0.00% --
Score 0.01 --
Div. Sustainability Score 0
Div.Growth Potential Score 0
Div. Directional Score 0 --
Next Divdend (Est)
(2024-05-06)
$0 Estimate 0.00 %
Dividend Stability
0.00 Very Bad
Dividend Score
0.01
Pay Frequency
Insufficient data to determine frequency
Yearly Payout
Year Amount Yield
2011 $0 0.00%
2012 $0 0.00%
2013 $0 0.00%
2014 $0 0.00%
2015 $0 0.00%
2016 $0 0.00%
2017 $0 0.00%
2018 $0 0.00%
2019 $0 0.00%
2020 $0 0.00%
2021 $0 0.00%
2022 $0 0.00%
2023 $0 0.00%
2024 $0 0.00%

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Top 10 dividend Companies for TSX

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
XMV.TO Dividend Junior 2023-06-26 Quarterly 13 1.48%
QUU.TO Dividend Knight 2023-09-18 Quarterly 7 0.80%
FST.TO Dividend Junior 2023-06-29 Quarterly 8 1.10%
AIF.TO Dividend Knight 2023-09-28 Quarterly 17 0.65%
VE.TO Dividend Junior 2023-06-30 Quarterly 11 1.75%
MUB.TO Dividend Knight 2023-09-01 Monthly 9 2.32%
DIR-UN.TO Dividend King 2023-07-28 Monthly 11 2.82%
YXM.TO No Dividend Player 2023-09-22 Annually 12 0.42%
SAP.TO Dividend King 2023-09-01 Quarterly 27 1.31%
HCG.TO Dividend Knight 2023-08-30 Annually 21 0.58%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM-9.761.500-10.00-10.00[0 - 0.5]
returnOnAssetsTTM-2.991.200-10.00-10.00[0 - 0.3]
returnOnEquityTTM1.6291.50010.0010.00[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM0.4030.800-2.99-2.39[1 - 3]
quickRatioTTM0.3660.800-2.55-2.04[0.8 - 2.5]
cashRatioTTM0.2881.5009.5110.00[0.2 - 2]
debtRatioTTM1.547-1.50010.00-10.00[0 - 0.6]
interestCoverageTTM-8.771.000-4.36-4.36[3 - 30]
operatingCashFlowPerShareTTM-0.03852.00-0.0128-0.0257[0 - 30]
freeCashFlowPerShareTTM-0.03912.00-0.0196-0.0391[0 - 20]
debtEquityRatioTTM-0.487-1.500-1.9482.92[0 - 2.5]
grossProfitMarginTTM-0.3211.000-8.68-8.68[0.2 - 0.8]
operatingProfitMarginTTM-7.321.000-10.00-10.00[0.1 - 0.6]
cashFlowToDebtRatioTTM-1.3301.000-8.50-8.50[0.2 - 2]
assetTurnoverTTM0.3070.800-1.289-1.031[0.5 - 2]
Total Score-3.25

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-7.681.000-0.8760[1 - 100]
returnOnEquityTTM1.6292.5010.0010.00[0.1 - 1.5]
freeCashFlowPerShareTTM-0.03912.00-0.0130-0.0391[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM-0.03852.00-0.0128-0.0257[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM0.05361.500-2.980[0.5 - 2]
operatingCashFlowSalesRatioTTM-6.711.000-10.000[0.1 - 0.5]
Total Score-0.539

Spectral Medical Inc

Spectral Medical Inc., together with its subsidiaries, focuses on the development and commercialization of products for the treatment of septic shock and renal disease in North America. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops and manufactures monoclonal and polyclonal antibodies, recombinant cardiac proteins, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies; and develops platform for renal replacement therapy. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada.

Über Live-Signale

Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.

Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.